The ERS Research Agency: the beginning

The modern research environment is much more complex and challenging than before [1]. Mechanistic research has become increasingly sophisticated and specialised, while new clinical research approaches have vastly increased the amount of data generated. These new developments bring a number of challenges. As part of its 2013–2018 strategic plan, the European Respiratory Society launches the ERS Research Agency http://ow.ly/WZyac

[1]  Brijesh Singh,et al.  The Lean Startup:How Today's Entrepreneurs Use Continuous Innovation to Create Radically Successful Businesses , 2016 .

[2]  E. Emanuel.  Reform of Clinical Research Regulations. , 2016, New England Journal of Medicine.

[3]  E. Emanuel.  Reform of Clinical Research Regulations, Finally. , 2015, The New England journal of medicine.

[4]  S. Holgate,et al.  The current state of respiratory research in the UK , 2015, Thorax.

[5]  A. Agustí,et al.  Drug development for airway diseases: looking forward , 2015, Nature Reviews Drug Discovery.

[6]  Jeffrey M Drazen,et al.  Sharing individual patient data from clinical trials. , 2015, The New England journal of medicine.

[7]  S. Brandon,et al.  Protection of personal data , 2004 .

[8]  K. Rabe,et al.  New metrics for translational research. , 2014, The Lancet Respiratory Medicine.

[9]  A. Simonds,et al.  The European Respiratory Society plans its future: the 2013–2018 strategic plan , 2014, European Respiratory Journal.

[10]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[11]  R. Hubbard.  The burden of lung disease , 2006, Thorax.

[12]  N. Powe,et al.  The relation between funding by the National Institutes of Health and the burden of disease. , 1999, The New England journal of medicine.

[13]  The Lancet Respiratory Medicine.  Data protection: balancing personal privacy and public health. , 2016, The Lancet Respiratory Medicine.

[14]  A. Regli,et al.  Big problem, small incidence, and large registry datasets. , 2016, The Lancet Respiratory Medicine.

[15]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .